Please enable JS

About Us

MANAGEMENT TEAM

CRISPR Therapeutics is led by a seasoned management team focused on translating CRISPR/Cas9 technology into transformative gene-based medicines for patients with serious diseases. We are working in parallel with our world-class group of scientific founders and advisors, who have extensive experience in gene editing, stem cell biology, advanced drug delivery technologies, RNAi and gene silencing.
 

DR. SAMARTH KULKARNI
Chief Executive Officer
DR. RODGER NOVAK
President and Founder
DR. TYLER DYLAN-HYDE
Chief Legal Officer
DR. TONY HO
Head of Research and Development
JIM KASINGER
General Counsel and Secretary to the Board of Directors
DR. LAWRENCE KLEIN
Head of Corporate Development and Strategy
DR. SVEN ANTE (BILL) LUNDBERG
Chief Scientific Officer
MEGAN WHERRY MENNER
Head of Human Resources
DR. KALA SUBRAMANIAN
Head of Strategic Development and Operations
DR. JON TERRETT
Head of Immuno-Oncology Research and Translation
MICHAEL TOMSICEK
Chief Financial Officer